According to a new market research study titled ‘Sleep Apnea Devices Market to 2025 – Global Analysis and Forecasts by Diagnostic Devices, Therapeutic Devices and End-Users, the global sleep apnea devices market was valued at US$ 4,607.9 Mn in 2017 and is estimated to reach US$ 8,305.3 Mn by 2025. The report highlights the trends prevalent in the global sleep apnea devices market and the factors driving the market along with those that act as deterrents to its growth.

The global sleep apnea devices market is a matured market in the developing countries as well as developing economies worldwide. Key factors driving the growth of the market are increased usage of oral devices and technological developments by major players. For instance, in May 2017, Fisher & Paykel launched the advanced F&P SleepStyle CPAP Device which are developed for the usage in the diagnosis and treatment of sleep specialists and obstructive sleep apnea or OSA patients. In May 2017, ResMed launched AirTouch F20 full face mask with UltraSoft memory foam mask cushion, which is a game-changer for patients with sleep apnea. The product is compatible with any CPAP that includes AirMini. Additionally, rising geriatric population suffering from sleep apnea also supports the market growth. Various countries across the globe focus on creating awareness about sleep apnea among the general population, to initiate early diagnosis and treatment.

The global sleep apnea market has been segmented, based on different parameters such as diagnostic devices, therapeutic devices, end-users and geographical regions. Based on diagnostic devices, global sleep apnea devices market is segmented as polysomnography devices, respiratory polygraphs, actigraphy systems and single-channel screening (oximeters) devices. The polysomnography devices segment has the largest market share among the type segment. Based on therapeutic devices, the sleep apnea devices market is segmented into facial interfaces, Adaptive Servo-Ventilation Instruments (ASV), Positive Airway Pressure (PAP) Devices, oxygen concentrators, airway clearance systems, oral appliances and accessories. Positive Airway Pressure (PAP) Devices has the largest market share among the therapeutic device segment. Based on end user, the global sleep apnea devices market is segmented into hospitals and home. The hospital segment has the largest market share among the end user segment. Geographically, the market for sleep apnea devices is segmented into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).

The key players operating in the field of sleep apnea devices worldwide include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel, Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd., Fisher & Paykel Healthcare Limited, SomnoMed Limited, Weinmann Emergency Medical Technology GmbH + CO. KG, Devilbiss Healthcare LLC and others.

The report segments the global Sleep Apnea Devices market as follows:

Global Sleep Apnea Devices Market – By Diagnostic Device

Polysomnography Devices
Respiratory Polygraphs
Actigraphy Systems
Single-Channel Screening (Oximeters) Devices

Global Sleep Apnea Devices Market – By Therapeutic Device

Facial Interfaces
Adaptive Servo-Ventilation Instruments (ASV)
Positive Airway Pressure (PAP) Devices
Oxygen Concentrators
Airway Clearance Systems
Oral Appliances
Accessories

Global Sleep Apnea Devices Market – By End-User

Home Healthcare
Sleep Laboratories & Hospitals
Global Sleep Apnea Devices Market – By Geography

North America
US
Canada
Mexico

Europe
UK
Germany
France

Asia Pacific (APAC)
Japan
China
India

Middle East & Africa (MEA)
South Africa
UAE

South America (SAM)
Brazil